AAAAAA

   
Results: 1-8 |
Results: 8
ANTITHROMBIN-III IN PATIENTS WITH SEVERE SEPSIS - A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND MULTICENTER TRIAL PLUS A METAANALYSIS ON ALL RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND TRIALS WITH ANTITHROMBIN-III IN SEVERE SEPSIS
Authors: EISELE B LAMY M THIJS LG KEINECKE HO SCHUSTER HP MATTHIAS FR FOURRIER F HEINRICHS H DELVOS U
Citation: B. Eisele et al., ANTITHROMBIN-III IN PATIENTS WITH SEVERE SEPSIS - A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND MULTICENTER TRIAL PLUS A METAANALYSIS ON ALL RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND TRIALS WITH ANTITHROMBIN-III IN SEVERE SEPSIS, Intensive care medicine, 24(7), 1998, pp. 663-672
EFFECT OF CL INHIBITOR ON INFLAMMATORY AND PHYSIOLOGICAL-RESPONSE PATTERNS IN PRIMATES SUFFERING FROM LETHAL SEPTIC SHOCK
Authors: JANSEN PM EISELE B DEJONG IW CHANG A DELVOS U TAYLOR FB HACK CE
Citation: Pm. Jansen et al., EFFECT OF CL INHIBITOR ON INFLAMMATORY AND PHYSIOLOGICAL-RESPONSE PATTERNS IN PRIMATES SUFFERING FROM LETHAL SEPTIC SHOCK, The Journal of immunology, 160(1), 1998, pp. 475-484
EFFECTS OF A NOVEL 2,3-OXIDOSQUALENE CYCLASE INHIBITOR ON CHOLESTEROL-BIOSYNTHESIS AND LIPID-METABOLISM IN-VIVO
Authors: EISELE B BUDZINSKI R MULLER P MAIER R MARK M
Citation: B. Eisele et al., EFFECTS OF A NOVEL 2,3-OXIDOSQUALENE CYCLASE INHIBITOR ON CHOLESTEROL-BIOSYNTHESIS AND LIPID-METABOLISM IN-VIVO, Journal of lipid research, 38(3), 1997, pp. 564-575
EFFECTS OF A NOVEL 2,3-OXIDOSQUALENE CYCLASE INHIBITOR ON THE REGULATION OF CHOLESTEROL-BIOSYNTHESIS IN HEPG2 CELLS
Authors: MARK M MULLER P MAIER R EISELE B
Citation: M. Mark et al., EFFECTS OF A NOVEL 2,3-OXIDOSQUALENE CYCLASE INHIBITOR ON THE REGULATION OF CHOLESTEROL-BIOSYNTHESIS IN HEPG2 CELLS, Journal of lipid research, 37(1), 1996, pp. 148-158
CARDIOPROTECTIVE EFFECT OF INTRACORONARY C1-ESTERASE-INHIBITOR ADMINISTRATION AFTER MYOCARDIAL-ISCHEMIA
Authors: HORSTICK G HEIMANN A HAFFNER G BERG O BOHMER P BECKER P EISELE B BHAKDI S KEMPSKI O
Citation: G. Horstick et al., CARDIOPROTECTIVE EFFECT OF INTRACORONARY C1-ESTERASE-INHIBITOR ADMINISTRATION AFTER MYOCARDIAL-ISCHEMIA, Circulation, 94(8), 1996, pp. 2850-2850
LEVELS OF THE TERMINAL COMPLEMENT COMPLEX, C3A-DESARG AND C1-INHIBITOR IN ADULT PATIENTS WITH CAPILLARY LEAK SYNDROME FOLLOWING BONE-MARROWTRANSPLANTATION
Authors: SALAT C HOLLER E SCHLEUNING M EISELE B REINHARDT B KOLB H PIHUSCH R DOMRATH R HILLER E
Citation: C. Salat et al., LEVELS OF THE TERMINAL COMPLEMENT COMPLEX, C3A-DESARG AND C1-INHIBITOR IN ADULT PATIENTS WITH CAPILLARY LEAK SYNDROME FOLLOWING BONE-MARROWTRANSPLANTATION, Annals of hematology, 71(6), 1995, pp. 271-274
C1-INHIBITOR IN THE VASCULAR LEAK SYNDROME - REPLY
Authors: HACK CE OGILVIE AC EISELE B EERENBERG AJM WAGSTAFF J THIJS LG
Citation: Ce. Hack et al., C1-INHIBITOR IN THE VASCULAR LEAK SYNDROME - REPLY, Intensive care medicine, 20(3), 1994, pp. 242-242
ACTIVITY OF C1 ESTERASE INHIBITOR IN PATIENTS WITH VASCULAR LEAK SYNDROME AFTER BONE-MARROW TRANSPLANTATION
Authors: NURNBERGER W MICHELMANN I PETRIK K HOLTHAUSEN S WILLERS R LAUERMANN G EISELE B DELVOS U BURDACH S GOBEL U
Citation: W. Nurnberger et al., ACTIVITY OF C1 ESTERASE INHIBITOR IN PATIENTS WITH VASCULAR LEAK SYNDROME AFTER BONE-MARROW TRANSPLANTATION, Annals of hematology, 67(1), 1993, pp. 17-21
Risultati: 1-8 |